Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol

References

• ATALL A., BREYER-PFAFF, U. and MASER, E., 1999, Carbonyl reductase and three aldo-keth reductases responsible for NNK carbonyl reduction in human liver cytosol. Naunyn-Schmiedeberg's Archives of Pharmacology, Suppl. 359, R154.
   Google Scholar
• ATALLA, A. and MASER, E., 1999, Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy1)-1-butamne (NNK) in cytosol of mouse liver and lung. Toxicology, 139, 155–166.
   PubMed Web of Science ®Google Scholar
• BELINSKY, S. A., SWAFFORD, B. S., FINCH, G. L., MITCHELL, C. E., KELLY, G., HAHN, F. F., ANDERSON, M. W. and NIKULA, K. J., 1997, Alterations in the K-ras and p53 genes in rat lung tumors. Environmental Health Perspectives, 105 (suppl. 4), 901–906.
   PubMedGoogle Scholar
• BOHREN, K. M., WERMUTH, B., HARRISON, D., RING, D., PETSKO, G. A. and ABBY, K. H., 1994, Expression, crystallization and preliminary crystallographic analysis of human carbonyl reductase. Journal of Molecular Biology, 244, 659–664.
   PubMed Web of Science ®Google Scholar
• BRADFORD, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of proteins using the principle of dye-binding. Analytical Biochemistry, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• BREYER-PFAFF, U. and NILL, K., 2000, High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver. Biochemical Pharmacology, 59, 249–260.
   PubMed Web of Science ®Google Scholar
• CARMELLA, S. G., AKERKAR, S. and HECHT, S. S., 1993, Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy1)-1-bitanone in smokers' urine. Cancer Research, 53, 721–724.
   PubMed Web of Science ®Google Scholar
• CARMELLA, S. G., AKERKAR, S. A., RICHIE, J. P. and HECHT, S. S., 1995, Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridy1)-1-butamne (NNK) in smoker's urine. Cancer Epidemiology Biomarkers and Prevention, 4, 635–652.
   PubMed Web of Science ®Google Scholar
• CARMELLA, S. G., BORUKHOVA, A., AKERKAR, S. A. and HECHT, S. S., 1997, Analysis of human urine for pyridine-N-oxide metabolites of 4-(methy1nitrosamino)-1-(3-pyridy1)-1-butmone, a tobacco-specific lung carcinogen. Cancer Epidemiology Biomarkers and Preventicn, 6, 113–120.
   PubMed Web of Science ®Google Scholar
• CASTONGUAY, A., LIN, D., STONER, G. D., RADOK, P., FURUYA, K., HECHT, S. S., SCHUT, H. A. J. and KLAUNIG, J. E., 1983a, Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N'-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone, and their analogues. Cancer Research, 43, 1223–1229.
   Google Scholar
• CASTONGUAY, A., STONER, G. D., SCHUT, H. A. and HECHT, S. S., 1983b, Metabolism of tobacco-specific N-nitros amines by cultured human tissues. Proceedings of the National Academy of Sciences, USA, 80, 6694–6697.
   PubMed Web of Science ®Google Scholar
• CRESPI, C. L., PENMAN, B. W., GELBOIN, H. V. and GONZALEZ, F. J., 1991, A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridy1)-1-buttnone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis, 12, 1197–1201.
   PubMed Web of Science ®Google Scholar
• DEYASHIKI, Y., TANIGUCHI, H., AMANO, T., NAKAYAMA, T., HARA, A. and SAWADA, H., 1992, Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3 alpha-hydroxysteroid dehydrogenase activity. Biochemical journal, 282, 741–746.
   PubMed Web of Science ®Google Scholar
• FISCHER, S., SPIEGELHALDER, B., EISENBARTH, J. and PREUSSMANN, R., 1990, Investigations On the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis, 11, 723–730.
   PubMed Web of Science ®Google Scholar
• FLYNN, T. G. and GREEN, N. C., 1993, The aldo-keto reductases: an overview. Advances in Experimental Medicine and Biology, 328, 251–257.
   PubMedGoogle Scholar
• HARA, A., MATSUURA, K., TAMADA, Y., SATO, K., MIYABE, Y., DEYASHIKI, Y. and ISHIDA, N., 1996a, Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. Biochemical Journal, 313, 373–376.
   PubMed Web of Science ®Google Scholar
• HARA, A., MATSUURA, K., TAMADA, Y., SATO, K., MIYABE, Y., DEYASHIKI, Y. and ISHIDA, N., 1996b, Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. Biochemical Journal, 313, 373–376.
   PubMed Web of Science ®Google Scholar
• HARA, A., TANIGUCHI, H., NAKAYAMA, T. and SAWADA, H., 1990, Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. Journal of Biochemistry, Tokyo, 108, 250–254.
   PubMedGoogle Scholar
• HECHT, S. S., 1994, Metabolic activation and detoxification of tobacco-specific nitrosamines — a model for cancer prevention strategies. Drug Metabolism Reviews, 26, 373–390.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S., 1996, Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butamne (NNK), a tobacco-specific lung carcinogen. Critical Reviews in Toxicology, 26, 163–181.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S., 1998, Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical Research in Toxicology, 11, 559–603.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S., CARMELLA, S. G., MURPHY, S. E., AKERKAR, S., BRUNNEMANN, K. D. and HOFFMANN, D., 1993a, A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. New England Journal of Medicine, 329, 1543–1546.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S. and HOFFMANN, D., 1988, Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875–884.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S. and HOFFMANN, D., 1989, The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surveys, 8, 273–294.
   PubMedGoogle Scholar
• HECHT, S. S., SPRATT, T. E. and TRUSHI N., 1997, Absolute configuration of 4-(methylnitrosamino)-1- (3-pyridy1)-1-butand formed metabolically from 4- (methylnitrosamino)-1-(3-pyridy1)-1-butanone. Carcinogenesis, 18, 1851–1854.
   PubMedGoogle Scholar
• HECHT, S. S., TRUSHIN, N., REID QUINN, C. A., BURAK, E. S., JONES, A. B., SOUTHERS, J. L., GOMBAR, C. T., CARMELLA, S. G., ANDERSON, L. M. and RICE, J. M., 1993b, Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis, 14, 229–236.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S., YOUNG, R. and CHEN, C. B., 1980, Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridy1)-1-butanone, a tobacco-specific carcinogen. Cancer Research, 40, 4144–4150.
   PubMed Web of Science ®Google Scholar
• INAzu, N., RUEPP, B., WIRTH, H. and WERMUTH, B., 1992, Carbonyl reductase from human testis: purification and comparison with carbonyl reductase from human brain and rat testis. Biochimka et Biophysica Acta, 1116, 50–56.
   PubMed Web of Science ®Google Scholar
• JEz, J. M., FLYNN, T. G. and PENNING, T. M., 1997, A nomenclature system for the aldo-keth reductase superfamily. Advances in Experimental Medicine and Biology, 414, 579–589.
   PubMedGoogle Scholar
• JoRNVALL, H., PERSSON, B., KROOK, M., ATRIAN, S., GONZALEZ-DUARTE, R., JEFFERY, J. and GHOSH, D., 1995, Short-chain dehydrogenases/reductases (SDR). Biochemistry, 34, 6003–6013.
   Google Scholar
• LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• MASER, E., 1995, Xenobiotic carbonyl reduction and physiological steroid oxidoreduction—the pluripotency of several hydroxysteroid dehydrogenases. Biochemical Pharmacology, 49,421–440.
   PubMed Web of Science ®Google Scholar
• MASER, E., 1997, Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? Trends in Pharmacological Sciences, 18, 270–275.
   Google Scholar
• MASER, E., 1998,11fl-Hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4 -(methylnitrosamino)-1 -(3 -pyridy1)-1-butanone in mouse lung micro somes. Cancer Research, 58, 2996–3003.
   PubMed Web of Science ®Google Scholar
• MASER, E. and BANNENBER G., 1994, 11/4-Hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds. Biochemical Pharmacology, 47, 1805–1812.
   Google Scholar
• MASER, E., RICHTER, E. and FRIEBERTSHAUSER, J., 1996, The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone. European Journal of Biochemistry, 238, 484–489.
   PubMedGoogle Scholar
• MASER, E., STINNER, B. and ATALL A., 2000, Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) by cytosolic enzymes in human liver and lung. Cancer Letters, 148, 135–144.
   PubMed Web of Science ®Google Scholar
• MATSUURA, K., DEYASHIKI, Y., SATO, K., ISHIDA, N., MIWA, G. and HAR A., 1997, Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis. Biochemical Journal, 323, 61–64.
   PubMed Web of Science ®Google Scholar
• MEGER, M., RICHTER, E., ZWICKENPFLUG, W., OEHLMANN, C., HARGADEN, M. B., A-Rmum, Y. I. and VESELL, E. S., 1999, Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) in rhesus monkeys. Drug Metabolism and Disposition, 27, 471–478.
   Google Scholar
• MOLOWA, D. T., SHAYNE, A. G. and GUZELIAN, P. S., 1986, Purification and characterization of chlordecone reductase from human liver. Journal of Biological Chemistry, 261, 12624–12627.
   PubMed Web of Science ®Google Scholar
• MORSE, M. A., EKLIND, K. I., TOUSSAINT, M., AMIN, S. G. and CHUNG, F. L., 1990, Characterization of a glucuronide metabolite of 4-(methyl-nitrosamino)-1-(3-pyridy1)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis, 11, 1819–1823.
   PubMed Web of Science ®Google Scholar
• MURPHY, S. E., HEIBLUM, R. and TRUSHI N., 1990a, Comparative metabolism of N'-nitro-sonornicotine and 4-(methylnitrosamino)-1-(3-pyridy1)-1-bitanone by cultured F344 rat oral tissue and esophagus. Cancer Research, 50, 4685–4691.
   PubMed Web of Science ®Google Scholar
• MURPHY, S. E., PALOMINO, A., HECHT, S. S. and HOFFMANN, D., 1990b, Dose—response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridy1)-1-bitanone in F344 rats. Cancer Research, 50, 5446–5452.
   PubMed Web of Science ®Google Scholar
• RICHTER, E., ENGL, J. and TRICKER, A. R., 1998, Metabolism of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) and 4-(methy1nitrosamino)-1-(3-pyridy1)-1-butaml (NNAL) in precision-cut human and rodent liver and lung tissue slices. Toxicological Sciences, 42 (suppl. 1), 183.
   Google Scholar
• RICHTER, E. and TRICKER, A. R., 1994, Nicotine inhibits the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy1)-1-bitanone in rats. Carcinogenesis, 15, 1061–1064.
   PubMed Web of Science ®Google Scholar
• SCHRADER, E., HIRSCH-ERNST, K. I., RICHTER, E. and FOTH, H., 1998, Metabolism of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butamne (NNK) in isolated rat lung and liver. Naunyn-Schmiedeberg's Archives of Pharmacology, 357, 336–343.
   Google Scholar
• SCHULZE, J., SCHRADER, E., FOTH, H., KAHL, G. F. and RICHTER, E., 1998, Effect of nicotine or cotinine on metabolism of 4-methylnitrosamino-1-(3-pyridy1)-1-butancne (NNK) in isolated rat lung and liver. Naunyn-Schmiedeberg's Archives of Pharmacology, 357, 344–350.
   PubMedGoogle Scholar
• SCHULZE, J., SCHLA GER, W., WUNSCH, R. and RICHTER, E., 1996, Metabolism of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanore (NNK) by hamster, mouse and rat intestine: relevance of species differences. Carcinogenesis, 17, 1093–1099.
   PubMedGoogle Scholar
• SMITH, T. J., LIAO, A. M., Liu, Y., BUTLER JONES, A., ANDERSON, L. M. and YANG, C. S., 1997, Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridy1)-1-bitanone in patas monkey lung and liver microsomes. Carcinogenesis, 18, 1577–1584.
   PubMed Web of Science ®Google Scholar
• STOLZ, A., HAMMOND, L., Lou, H., TAKIKAWA, H., RONK, M. and SHIVELY, J. E., 1993, cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. Journal of Biological Chemistry, 268, 10448–10457.
   PubMed Web of Science ®Google Scholar
• TAKIKAWA, H., STOLZ, A., SUGIYAMA, Y., YOSHIDA, H., YAMANAKA, M. and KAPLOWITZ, N., 1990, Relationship between the newly identified bile acid binder and bile acid oxidoreductases in human liver. Journal of Biological Chemistry, 265, 2132–2136.
   PubMed Web of Science ®Google Scholar
• UPADHYAYA, P., KENNEY, P. M., HOCHALTER, J. B., WANG, M. and HECHT, S. S., 1999, Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridy1)-1-bitanol enantiomers and metabolites in the A/J mouse. Carcinogenesis, 20, 1577–1582.
   PubMed Web of Science ®Google Scholar
• VEECH, R. L., EGGLESTON, L. V. and KREBS, H. A., 1969, The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochemical Journal, 115, 609–619.
   PubMed Web of Science ®Google Scholar
• VOGEL, K., BENTLEY, P., PLATT, K. L. and OESCH, F., 1980, Rat liver cytoplasmic dihydrodiol dehydrogenase. Purification to apparent homogeneity and properties. Journal of Biological Chemistry, 255, 9621–9635.
   PubMed Web of Science ®Google Scholar
• WERMUTH, B., 1981, Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Journal of Biological Chemistry, 256, 1206–1213.
   PubMed Web of Science ®Google Scholar
• WERMUTH, B., 1985, Aldo-keto reductases. In T. G. Flynn and H. Weiner (eds), Enzymology of Carbonyl Metabolism: Aldehyde Dehydrogenase, AldolKeto Reductax, and Alcohol Dehydrogenase (New York: Alan R. Liss), pp. 209–230.
   Google Scholar
• WERMUTH, B., BOHREN, K. M., HEINEMANN, G., VON WARTBURG, J. P. and GABBAY, K. H., 1988, Human carbonyl reductase. Nucleotide sequence analysis of a cDNA and amino acid sequence of the encoded protein. Journal of Biological Chemistry, 263, 16185–16188.
   PubMed Web of Science ®Google Scholar
• WERMUTH, B., PLATT, K. L., SEIDEL, A. and OESCH, F., 1986, Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Biochemical Pharmacology, 35, 1277–1282.
   PubMed Web of Science ®Google Scholar